Tevogen Bio Holdings Inc. (NASDAQ: TVGN)
$1.4100
-0.0900 ( -5.37% ) 1.5M
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Market Data
Open
$1.4100
Previous close
$1.5000
Volume
1.5M
Market cap
$255.23M
Day range
$1.3870 - $1.6380
52 week range
$0.2556 - $21.0900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 67 | Nov 19, 2024 |
| nt | Quarterly Reports | 1 | Nov 15, 2024 |
| 4 | Insider transactions | 1 | Oct 18, 2024 |
| 8-k/a | 8K-related | 15 | Aug 26, 2024 |
| 8-k | 8K-related | 17 | Aug 23, 2024 |
| 10-q | Quarterly Reports | 68 | Aug 14, 2024 |
| 8-k | 8K-related | 15 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 13, 2024 |
| 8-k | 8K-related | 16 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 07, 2024 |